LN-229 cells
Catalog #:
C0005017
Shipping advice:
Use only Express Delivery (overnight) for cell line. International shipping rate please contact us for details
| Frozen vial | USD420.0 |
 |
Disease:
Glioblastoma
Origin:
The LN-229 cell line was established in 1979 from cells taken from a patient with right frontal parieto-occipital glioblastoma.
Species:
Homo sapiens, human
Brain/right frontal parieto-occipital cortex
Epithelial
Adherent
Caucasian, female, 60 years of age
AddexBio-formulated DMEM (C0003-01) + 5% FBS
Subculture at a ratio of 1:4 to 1:6 using 0.25% (w/v) Trypsin- 0.53 mM EDTA solution. Culture at 5% CO2, 37°C.
Complete growth culture medium supplemented with 5% (v/v) DMSO I
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
HIV: Negative
Hepatitis B: Negative
Amelogenin: X
CSF1PO: 12
D13S317: 10,11
D16S539: 12
D5S818: 11,12
D7S820: 8,11
THO1:9.3
TPOX: 8
vWA: 16,19
If use of this culture results in a scientific publication, it should be cited in the publication as: LN-229 (AddexBio C0005017)
Tissue:
Morphology:
Properties:
Patient:
Medium:
Subculture:
Freezing Medium:
Biosafety Level:
Sterility:
Pathogens:
DNA Profile (STR):
Citation Format:
References for LN-229 cells:
1. Diserens AC, de Tribolet N, Martin-Achard A, Gaide AC, Schnegg JF, Carrel S. Characterization of an established human malignant glioma cell line: LN-18. Acta Neuropathol. 1981;53(1):21-28. PMID: 7211194
